Literature DB >> 19465283

Patient satisfaction and visual function after pseudophakic monovision.

Yaron M Finkelman1, Jonathon Q Ng, Graham D Barrett.   

Abstract

PURPOSE: To evaluate the visual outcomes and patient satisfaction with modified pseudophakic monovision.
SETTING: Tertiary teaching hospital.
METHODS: This prospective study comprised patients with emmetropia after first-eye cataract surgery who were offered monovision for the second-eye surgery with a moderate myopic target refraction (-1.00 to -1.50 diopters [D]). Visual acuity, contrast sensitivity, stereopsis, patient satisfaction, and degree of spectacle independence were measured preoperatively and 3 to 4 months postoperatively.
RESULTS: The study evaluated 52 eyes of 26 patients with a mean anisometropia between the near eye and the distance eye of 1.16 D. Uncorrected distance visual acuity was at least 20/30 in 96% of patients, with 92% achieving N8 (J4) or better uncorrected near acuity. Good stereopsis and contrast sensitivity were maintained. Patients were generally satisfied with the surgery. One fourth of patients were completely independent of spectacles; 1 patient was totally dependent on spectacles. No patient required intraocular lens (IOL) exchange or other refractive corrective procedures.
CONCLUSION: Monovision with modest refractive targets achieved good visual function and patient satisfaction without the inherent risk for troublesome visual symptoms associated with multifocal IOLs.

Entities:  

Mesh:

Year:  2009        PMID: 19465283     DOI: 10.1016/j.jcrs.2009.01.035

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  22 in total

1.  Stereopsis in bilaterally multifocal pseudophakic patients.

Authors:  Teresa Ferrer-Blasco; David Madrid-Costa; Santiago García-Lázaro; Alejandro Cerviño; Robert Montés-Micó
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-02       Impact factor: 3.117

2.  Cataract surgery.

Authors:  Jonathan A Micieli; Steve A Arshinoff
Journal:  CMAJ       Date:  2011-08-08       Impact factor: 8.262

Review 3.  A systematic review of pseudophakic monovision for presbyopia correction.

Authors:  Georgios Labiris; Aspa Toli; Aslin Perente; Panagiota Ntonti; Vassilios P Kozobolis
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

4.  Haigis and SRKT formulae accuracy for intentional myopic overcorrection.

Authors:  Rodrigo Faeda Dalto; Miriam A Ferreira; Wilian Queiroz; Roberto Pinto Coelho; Jayter Silva Paula; Andre Messias
Journal:  Int Ophthalmol       Date:  2017-06-21       Impact factor: 2.031

Review 5.  Clinical application of accommodating intraocular lens.

Authors:  You-Ling Liang; Song-Bai Jia
Journal:  Int J Ophthalmol       Date:  2018-06-18       Impact factor: 1.779

6.  Binocular visual function of myopic pseudophakic monovision.

Authors:  Ken Hayashi; Motoaki Yoshida; Hiroshi Sasaki; Akira Hirata
Journal:  Jpn J Ophthalmol       Date:  2018-02-20       Impact factor: 2.447

7.  Etiology and outcomes of secondary surgical intervention for dissatisfied patients after pseudophakic monovision.

Authors:  Sayaka Kato; Misae Ito; Kimiya Shimizu; Kazutaka Kamiya
Journal:  Int Ophthalmol       Date:  2017-05-18       Impact factor: 2.031

8.  Modified monovision with spherical aberration to improve presbyopic through-focus visual performance.

Authors:  Len Zheleznyak; Ramkumar Sabesan; Je-Sun Oh; Scott MacRae; Geunyoung Yoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-05-03       Impact factor: 4.799

9.  Surgical management of presbyopia.

Authors:  André Am Torricelli; Jackson B Junior; Marcony R Santhiago; Samir J Bechara
Journal:  Clin Ophthalmol       Date:  2012-09-06

10.  Comparison of visual performance of multifocal intraocular lenses with same material monofocal intraocular lenses.

Authors:  Tomofusa Yamauchi; Hitoshi Tabuchi; Kosuke Takase; Hideharu Ohsugi; Zaigen Ohara; Yoshiaki Kiuchi
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.